AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
Go back to AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial| AtriCure, Inc. (NASDAQ: ATRC) | Delayed: 58.41 +0.03 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.38 | 52 Week High | $23.24 | |||
| Open | $57.56 | 52 Week Low | $13.44 | |||
| Day High | $58.49 | P/E | N/A | |||
| Day Low | $56.90 | EPS | $-0.45 | |||
| Volume | 1,161,794 | |||||
